{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:31Z","timestamp":1787026711834,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Identifying suitable animal models and standardizing preclinical methods are important for the generation, characterization, and development of new vaccines, including those against\n                    <jats:italic>Francisella tularensis<\/jats:italic>\n                    . Non-human primates represent an important animal model to evaluate tularemia vaccine efficacy, and the use of correlates of vaccine-induced protection may facilitate bridging immune responses from non-human primates to people. However, among small animals, Fischer 344 rats represent a valuable resource for initial studies to evaluate immune responses, to identify correlates of protection, and to screen novel vaccines. In this study, we performed a comparative analysis of three Fischer rat substrains to determine potential differences in immune responses, to evaluate methods used to quantify potential correlates of protection, and to evaluate protection after vaccination. To this end, we took advantage of data previously generated using one of the rat substrains by evaluating two live vaccines, LVS and\n                    <jats:italic>F. tularensis<\/jats:italic>\n                    SchuS4-\u0394\n                    <jats:italic>clpB<\/jats:italic>\n                    (\u0394\n                    <jats:italic>clpB<\/jats:italic>\n                    ). We compared immune responses after primary vaccination, adaptive immune responses upon re-stimulation of leukocytes\n                    <jats:italic>in vitro<\/jats:italic>\n                    , and sensitivity to aerosol challenge. Despite some detectable differences, the results highlight the similarity of immune responses to tularemia vaccines and challenge outcomes between the three substrains, indicating that all offer acceptable and comparable approaches as animal models to study\n                    <jats:italic>Francisella<\/jats:italic>\n                    infection and immunity.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2023.1224480","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T09:34:12Z","timestamp":1689240852000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["In vivo and in vitro immune responses against Francisella tularensis vaccines are comparable among Fischer 344 rat substrains"],"prefix":"10.3389","volume":"14","author":[{"given":"Roberto","family":"De Pascalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varunika","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Espich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Carl","family":"Gelhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Elkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/14740338.2018.1518429","article-title":"The FDA animal rule and its role in protecting human safety","volume":"17","author":"Allio","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1128\/jcm.22.2.212-215.1985","article-title":"Anti-microbial susceptibility testing of Francisella tularensis with a modified Mueller\u2013Hinton broth","volume":"22","author":"Baker","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"16013","DOI":"10.1038\/npjvaccines.2016.13","article-title":"First vaccine approval under the FDA animal rule","volume":"1","author":"Beasley","year":"2016","journal-title":"NPJ Vaccines"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1128\/IAI.69.1.194-203.2001","article-title":"Susceptibility to secondary Francisella tularensis LVS infection in B cell deficient mice is associated with neutrophilia but not with defects in specific T cell mediated immunity","volume":"69","author":"Bosio","year":"2001","journal-title":"Infect. Immun."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/infdis\/135.1.55","article-title":"Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia","volume":"135","author":"Burke","year":"1977","journal-title":"J. Infect. Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1016\/S0264-410X(03)00386-4","article-title":"Tularemia in BALB\/c and C57BL\/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background","volume":"21","author":"Chen","year":"2003","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1128\/IAI.01322-08","article-title":"T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria","volume":"77","author":"Collazo","year":"2009","journal-title":"Infect. Immun."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"19.14","DOI":"10.1002\/0471142735.im1914s93","article-title":"Infection of mice with Francisella as an immunological model","volume":"19","author":"Conlan","year":"2011","journal-title":"Curr. Protoc. Immunol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.vaccine.2009.12.001","article-title":"Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization","volume":"28","author":"Conlan","year":"2010","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"E1002494","DOI":"10.1371\/journal.ppat.1002494","article-title":"Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS","volume":"8","author":"De Pascalis","year":"2012","journal-title":"PLoS Pathog."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"E00936","DOI":"10.1128\/mBio.00936-13","article-title":"Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis live vaccine strain (LVS)","volume":"5","author":"De Pascalis","year":"2014","journal-title":"mBio"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41541-022-00506-9","article-title":"Working correlates of protection predict SCHU S4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis","volume":"7","author":"De Pascalis","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"E0198140","DOI":"10.1371\/journal.pone.0198140","article-title":"A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis","volume":"13","author":"De Pascalis","year":"2018","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"E0126570","DOI":"10.1371\/journal.pone.0126570","article-title":"Francisella tularensis vaccines elicit concurrent protective T-and B-cell immune responses in BALB\/cByJ mice","volume":"10","author":"De Pascalis","year":"2015","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/IAI.01348-15","article-title":"Activities of murine peripheral blood lymphocytes provide immune correlates that predict Francisella tularensis vaccine efficacy","volume":"84","author":"De Pascalis","year":"2016","journal-title":"Infect. Immun."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4049\/jimmunol.87.4.415","article-title":"Prophylactic effectiveness of live and killed tularemia vaccines","volume":"87","author":"Eigelsbach","year":"1961","journal-title":"J. Immunol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/s1286-4579(02)00084-9","article-title":"Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain","volume":"5","author":"Elkins","year":"2003","journal-title":"Microbes Infect."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1196\/annals.1409.014","article-title":"Innate and adaptive immunity to Francisella","volume":"1105","author":"Elkins","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"14.25","DOI":"10.1002\/0471142735.im1425s93","article-title":"Measurement of macrophage-mediated killing of intracellular bacteria, including Francisella and mycobacteria","volume":"14","author":"Elkins","year":"2011","journal-title":"Curr. Protoc. Immunol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1128\/iai.59.9.2922-2928.1991","article-title":"Live vaccine strain of Francisella tularensis: infection and immunity in mice","volume":"59","author":"Fortier","year":"1991","journal-title":"Infect. Immun."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ajpath.2016.09.021","article-title":"The natural history of pneumonic tularemia in female Fischer 344 rats after inhalational exposure to aerosolized Francisella tularensis subspecies tularensis strain SCHU S4","volume":"187","author":"Hutt","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1128\/iai.34.3.766-772.1981","article-title":"Respiratory tularemia: comparison of selected routes of vaccination in Fischer 344 rats","volume":"34","author":"Jemski","year":"1981","journal-title":"Infect. Immun."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/pathogens10060638","article-title":"Identification of an attenuated substrain of Francisella tularensis SCHU S4 by phenotypic and genotypic analyses","volume":"10","author":"Lovchik","year":"2021","journal-title":"Pathogens"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/microorganisms9050973","article-title":"Differential immune response following intranasal and intradermal infection with Francisella tularensis: implications for vaccine development","volume":"9","author":"Nicol","year":"2021","journal-title":"Microorganisms"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"E9952","DOI":"10.1371\/journal.pone.0009952","article-title":"The Fischer 344 rat reflects human susceptibility to Francisella pulmonary challenge and provides a new platform for virulence and protection studies","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"112693","DOI":"10.1016\/j.jim.2019.112693","article-title":"rM-CSF efficiently replaces L929 in generating mouse and rat bone marrow-derived macrophages for in vitro functional studies of immunity to intracellular bacteria","volume":"477","author":"Rice","year":"2020","journal-title":"J. Immunol. Methods"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/archinte.1961.03620050068007","article-title":"Tularemia vaccine study. II. Respiratory challenge","volume":"107","author":"Saslaw","year":"","journal-title":"Arch. Intern. Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/archinte.1961.03620050055006","article-title":"Tularemia vaccine study. I. Intracutaneous challenge","volume":"107","author":"Saslaw","year":"","journal-title":"Arch. Intern. Med."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"E13349","DOI":"10.1371\/journal.pone.0013349","article-title":"Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy","volume":"5","author":"Shen","year":"2010","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/pathogens10121646","article-title":"The O-Ag antibody response to Francisella is distinct in rodents and higher animals and can serve as a correlate of protection","volume":"10","author":"Shoudy","year":"2021","journal-title":"Pathogens"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1177\/0300985810372506","article-title":"Establishing efficacy of human products using animals: the US Food and Drug Administration\u2019s \u201canimal rule\u201d","volume":"47","author":"Snoy","year":"2010","journal-title":"Vet. Pathol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3201\/eid1207.051504","article-title":"Epidemiologic and molecular analysis of human tularemia, United States, 1964\u20132004","volume":"12","author":"Staples","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1128\/jcm.22.4.527-530.1985","article-title":"Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine","volume":"22","author":"T\u00e4rnvik","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/br.26.3.354-373.1962","article-title":"Soviet viable Pasteurella tularensis vaccines. A review of selected articles","volume":"26","author":"Tigertt","year":"1962","journal-title":"Bacteriol. Rev."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1016\/j.vaccine.2012.03.036","article-title":"BALB\/c mice, but not C57BL\/6 mice immunized with a \u0394clpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses","volume":"30","author":"Twine","year":"2012","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmed.2019.00229","article-title":"Retrospective analysis of pneumonic tularemia in operation whitecoat human subjects: disease progression and tetracycline efficacy","volume":"6","author":"Williams","year":"2019","journal-title":"Front. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1224480\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T05:08:22Z","timestamp":1689916102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1224480\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":37,"alternative-id":["10.3389\/fmicb.2023.1224480"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1224480","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"article-number":"1224480"}}